Nexgenia Inc.
Biotechnology company · Seattle, Washington, United States
Nexgenia Inc. is a biotechnology company headquartered in Seattle, Washington, United States. Its earliest recorded incorporation is in 2011. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $1.5 million in total, most recently in 2016. It has reported private securities offerings to the US SEC, most recently $119,099 sold in a notice filed in 2018.
Nexgenia at a glance
What does Nexgenia do?
US government research funding
3 SBIR/STTR small-business research awards from US health agencies, $1.5 million in total (2012 to 2016). NIH funding came from the National Institute of Allergy and Infectious Diseases.
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $119,099 sold (2018).
Frequently asked questions about Nexgenia
Where is Nexgenia headquartered?
Nexgenia Inc. is headquartered in Seattle, Washington, United States.
What does Nexgenia do?
Nexgenia Inc. is a biotechnology company.
When was Nexgenia founded?
The earliest incorporation on record for Nexgenia Inc. is in 2011, according to public company registers.
Similar companies
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Kineta, Inc.Seattle, Washington, United States
- Avm Biotechnology, LLCSeattle, Washington, United States
- Lumen Bioscience, Inc.Seattle, Washington, United States
- Presage Biosciences, Inc.Seattle, Washington, United States
- Sana Biotechnology, Inc.Seattle, Washington, United States
- Phase Genomics, Inc.Seattle, Washington, United States
- Soovu Labs, Inc.Seattle, Washington, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences